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Abstract
This investigation sought to determine whether post-exercise cold water immersion and low glycogen availability, sepa-
rately and in combination, would preferentially activate either the Exon 1a or Exon 1b Peroxisome proliferator-activated 
receptor gamma coactivator 1-alpha (PGC-1α) promoter. Through a reanalysis of sample design, we identified that the 
systemic cold-induced augmentation of total PGC-1α gene expression observed previously (Allan et al. in J Appl Physiol 
123(2):451–459, 2017) was largely a result of increased expression from the alternative promoter (Exon 1b), rather than 
canonical promoter (Exon 1a). Low glycogen availability in combination with local cooling of the muscle (Allan et al. in 
Physiol Rep 7(11):e14082, 2019) demonstrated that PGC-1α alternative promoter (Exon 1b) expression continued to rise at 
3 h post-exercise in all conditions; whilst, expression from the canonical promoter (Exon 1a) decreased between the same 
time points (post-exercise–3 h post-exercise). Importantly, this increase in PGC-1α Exon 1b expression was reduced compared 
to the response of low glycogen or cold water immersion alone, suggesting that the combination of prior low glycogen and 
CWI post-exercise impaired the response in gene expression versus these conditions individually. Data herein emphasise the 
influence of post-exercise cooling and low glycogen availability on Exon-specific control of total PGC-1 α gene expression 
and highlight the need for future research to assess Exon-specific regulation of PGC-1α.
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Introduction
Recently, it has been shown that skeletal muscle expresses 
several different transcript variants that produce different 
protein isoforms of the transcriptional co-activator peroxi-
some proliferator-activated receptor gamma co-activator 
1-alpha (PGC-1α) (reviewed in Popov et al. 2015a). To 
date, more than eight alternative protein isoforms have 
been described in human skeletal muscle, where the gene 
expression of these variants is thought to occur via two alter-
nate promoter regions on the same gene (Popov et al. 2015a; 
Martinez-Redondo et al. 2016). The proximal (canonical) 
PGC-1α gene promoter (Exon 1a) is constitutively expressed 
at rest compared to the alternative promoter (Exon 1b), 
whilst the alternative promoter (Exon 1b) is more responsive 
following exercise (Martinez-Redondo et al. 2015; Popov 
et al. 2015b). In humans, gene expression of Exon 1c is not 
highly expressed post-exercise with levels reported to be 
very low to negligible (Popov et al. 2015b).
Whilst evidence exists that supports exercise regulation 
of PGC-1α via a program of expression of distinct transcript 
variants, the contribution of post-exercise cold water immer-
sion (CWI) or prior low muscle glycogen availability in the 
activation of PGC-1α via either the canonical (Exon 1a) or 
alternative (Exon 1b) promoter has not been determined. 
PGC-1α gene expression driven by exercise, cold and low 
glycogen stimuli is thought to be regulated by AMP-acti-
vated protein kinase (AMPK) (Norrbom et al. 2011; Wen 
et al. 2014) or β-adrenergic pathways (Chinsomboon et al. 
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2009; Tadaishi et al. 2011). Importantly, it has been sug-
gested that Exon 1a and 1b are AMPK activated, whilst 
Exon 1b is also susceptible to β-adrenergic stimulation 
(Popov et al. 2015a). Recently, Brandt et al. (2017) showed 
increased promoter-specific gene expression in mice follow-
ing a single injection of clenbuterol (a powerful β-adrenergic 
agonist), suggesting an important role for adrenergic signal-
ling. Cold water immersion has been consistently shown to 
raise post-exercise plasma normetanephrine concentrations 
to a greater extent than non-immersed conditions (Joo et al. 
2016; Allan et al. 2017), with post-exercise CWI augmenting 
the exercise-induced gene expression of total PGC-1α vs. a 
non-immersed control condition (Ihsan et al. 2014; Joo et al. 
2016; Allan et al. 2017). Therefore, of particular interest is 
whether the individual impact of exercise, cold stress and 
low glycogen would preferentially activate either the Exon 
1a or Exon 1b PGC-1α promoter, and whether the combined 
impact of these stimuli would further enhance PGC-1α gene 
expression.  Such mechanistic information would allow 
greater support for the application of post-exercise CWI in 
an applied setting, whilst going some way to assist the cor-
rect use and timing of such modalities.
Thus, the aim of the present study was to assess the 
impact of post-exercise cooling and prior low glycogen 
availability on PGC-1α promoter-specific mRNA expres-
sion. To this end, we completed new analysis on the same 
RNA derived from the recently published work completed 
in our lab in which both post-exercise local and systemic 
cooling of human skeletal muscle tissue was undertaken 
(Allan et al. 2017) and the impact of combined post-exercise 
cooling and low glycogen availability within skeletal muscle 
(Allan et al. 2019) was assessed. This allowed us to assess 
the post-exercise PGC-1α promoter variant response, with 
low glycogen availability and post-exercise cooling alone, 
as well as combined. It was hypothesised that cold water 
immersion and prior low glycogen would increase the exer-
cise-induced PGC-1α alternative (Exon 1b), yet based on 
recent evidence (Allan et al. 2019), the impact of combining 
these stressors was expected not to be advantageous.
Materials and methods
Ethical approval
All participants gave written informed consent to partici-
pate after details and procedures of studies had been fully 
explained. All participants had no history of neurological 
disease or musculoskeletal abnormality and none were under 
any pharmacological treatment during the course of the 
study. All procedures performed in the study were approved 
by Liverpool John Moores University Ethics Committee and 
in accordance with the 1964 Helsinki declaration and its 
later amendments.
Study overview
During this investigation, we undertook new analysis of 
existing RNA samples derived from previous work and 
methods are as previously published and shall be referred to 
herein as Experiment 1 (Allan et al. 2017) and Experiment 
2 (Allan et al. 2019) (see Fig. 1 for experimental designs).
Experimental design
For analysis of samples derived from Experiment 1 
(Allan et  al. 2017), participant data and experimental 
protocol have already been described; however, briefly, 
ten recreationally active healthy males (age 26 ± 4 years; 
body mass 79.29 ± 6.73 kg; height 180 ± 5 cm; V ̇O2peak 
51.46 ± 9.07  mL·kg−1·min−1 peak power output (PPO) 
265.2 ± 38.33 W; mean ± SD) participated in this study. Fol-
lowing pre-exercise assessments, participants completed a 
high-intensity intermittent cycling protocol (Lode Excalibur 
Sport, Lode, Netherlands) consisting of 8 × 5 min bouts at 
82.5% PPO separated by 1-min rest followed by either one-
legged CWI (CWI: 10 min at 8 ± 1 °C) or a control condition 
(CON; seated rest at room temperature).
In Experiment 2 (Allan et al. 2019), the impact of com-
bined post-exercise local cooling in combination with 
starting low glycogen content within skeletal muscle 
was assessed. Nine recreationally active healthy males 
(age 22 ± 3 years.; body mass 74.18 ± 7.88  kg; height 
180.50 ± 6.60 cm; peak power output (PPO) 271.8 ± 25.8 W; 
mean ± SD) participated in the study. Following a series of 
single- and double-leg glycogen-depleting protocols in the 
2 days prior to the experimental day, participants attended 
the lab with one limb higher in glycogen availability than 
the other (LOW ~ 190 mmol  kg−1dw and VLOW ~ 85 mmol 
 kg−1dw). Following pre-exercise assessments, participants 
completed a high-intensity intermittent cycling protocol 
(Lode Excalibur Sport, Lode, Netherlands) consisting of 
8 × 5 min bouts at 82.5% PPO separated by 1-min rest fol-
lowed by either two-legged CWI (CWI: 10 min at 8 ± 1 °C) 
or a control condition (CON; seated rest).
“For both Experiments”, participants were instructed 
to refrain from exercise, alcohol and caffeine 48 h prior to 
attending the lab. Participants were lowered and raised into 
and out of the water to the level of the iliac crest using an 
electronic hoist system, after which they remained seated 
in a semi-reclined position in normal laboratory tempera-
tures (~ 21 °C) until 3 h post-exercise. Muscle biopsies were 
obtained at pre-exercise, immediately post-exercise and 3 h 
post-exercise.
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Muscle analysis
Muscle biopsies were obtained from the vastus lateralis 
muscle under local anaesthesia (0.5% marcaine) using 
a Pro-Mag 2.2 biopsy gun (MD-TECH, Manan Medi-
cal Products, Northbrook, IL, USA). Each incision was 
anaesthetised individually and occurred at a distance of 
2–3 cm from the previous incision. Once obtained, sam-
ples (~ 30–50 mg of tissue) were immediately frozen in 
liquid nitrogen and stored at − 80 °C for later analysis.
Real‑time quantitative RT‑PCR
RNA extraction and quantitative real-time PCR was con-
ducted as previously described (Allan et al. 2017, 2019). 
Primer sequences (Table 1) were identified using Gene 
(NCBI, https ://www.ncbi.nlm.nih.gov/gene) and designed 
using Primer-BLAST (NCBI, https ://www.ncbi.nlm.nih.
gov/tools /prime r-blast /). Sequence homology searches 
ensured specificity and that all primers had no potential 
unintended targets. All primers were between 20 and 25 bp 
Fig. 1  Overview of the experimental protocol used in each 
trial. Whilst blood samples were collected in the original studies no 
new data herein is derived from blood.  HIIT high-intensity intermit-
tent exercise; CON control condition/limb; NOT non-immersed limb; 
CWI cold water immersion condition/limb; PPO peak power output; 
LOW low CHO limb; VLOW very low CHO limb
Table 1  Primer sequences used for real-time PCR
Exon 1a PGC-1α Exon 1a; Exon 1b PGC-1α Exon 1b




GAPDH NM_002046.5 AAG ACC TTG GGC TGG GAC TG TGG CTC GGC TGG CGAC 168 6–173
Total PGC-1_α NM_013261.3 TGC TAA ACG ACT CCG AGA A TGC AAA GTT CCC TCT CTG CT 67
Exon 1a
NM_013261.4
Recently updated to NM_013261.5




CTA TGG ATT CAA TTT TGA AAT GTG C CTG ATT GGT CAC TGC ACC AC 153 77–229
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and amplified a product of between 127 and 168 bp. Prim-
ers were purchased from Sigma (Suffolk, UK). For exon-
specific analysis, following the initial screening of suitable 
reference genes, GAPDH showed the most stable thresh-
old cycle  (CT) values across all RT-PCR runs and subjects 
regardless of experimental condition (27.02 ± 1.96  CT; 7% 
coefficient of variation) and was selected as the reference 
gene in all RT-PCR assays. The average PCR efficiency was 
90%, and variation for all target genes including the refer-
ence gene was low at 2.8%. The relative gene expression 
levels were calculated using the comparative  CT (ΔΔCT) 
equation (Schmittgen and Livak 2008), where the relative 
expression was calculated as  2–ΔΔCT and where  CT represents 
the threshold cycle. mRNA expression for all target genes 
was calculated relative to the reference gene (GAPDH; sub-
ject’s own sample reference) within the same subject and 
condition, and to a calibrator of pre-exercise.
Statistical analysis
Experiment 1
A two-factor (3 conditions x time), within-participants, gen-
eral linear model was used to evaluate the effect of time (pre-
exercise vs. post-exercise) with shared baseline data used for 
NOT and CWI (Statistical package for the Social Sciences 
version 21.0; SPSS, Chicago, IL). A two-factor (3 conditions 
x time), within-participants, general linear model was sub-
sequently used to evaluate the influence of the cooling inter-
vention following exercise and the 3-h post exercise period. 
Experiment 2
A two-factor (4 condition x time) within-participant’s gen-
eral linear model for condition (Low glycogen control (CON 
LOW), Very Low glycogen control (CON VLOW), Low gly-
cogen CWI (CWI LOW), Very Low glycogen CWI (CWI 
VLOW)) and time (Pre, Post, 3 h) was used to evaluate the 
influence of low glycogen availability and CWI following 
exercise and the 3-h post-exercise period.
“For both experiments”, the main effects for condition 
and time were followed up via the use of planned least 
significant difference (LSD) multiple contrasts. Where a 
significant condition-by-ime interaction was observed, the 
post-exercise to 3-h post-exercise change scores were calcu-
lated and compared across conditions using LSD multiple 
contrasts. The ES magnitude was classified as trivial (< 0.2), 
small (> 0.2–0.6), moderate (> 0.6–1.2), large (> 1.2–2.0) 
and very large (> 2.0–4.0) (Hopkins et al. 2009). Data are 
means ± SD unless otherwise stated. The α level for evalu-
ation of statistical significance was set at P < 0.05.
Results
Experiment 1
Exercise significantly increased the expression of Exon 
1a mRNA ~ two–four fold from Pre (Pre–Post-Exercise: 
P < 0.001, ES 2.50 Very Large, Fig. 2). In the 3-h post-
exercise recovery period, no change in level of expression 
was seen (P = 0.202, ES 0.27 Small) between conditions 
(P = 0.146, ES 0.74 Moderate). The change over time was 
significant (P = 0.05). Exercise also significantly increased 
the expression of Exon 1b mRNA (Pre–Post-Exercise: 
P = 0.016, ES 1.14 Large, Fig. 2). In the 3-h post-exer-
cise recovery period, Exon 1b expression increased sig-
nificantly (P = 0.007, ES 1.15 Large) between conditions 
(P = 0.011). Post hoc analysis showed NOT (2344-fold 
change from Pre, ES 1.12 Large) significantly increased 
Exon 1b gene expression compared to CON (579-fold 
change from Pre, P = 0.010) and CWI (1860-fold change 
from Pre, ES 0.61 Moderate) on average increased Exon 
1b gene expression versus CON, an observation that 
approached statistical significance (P = 0.07). No signifi-
cant change in Exon 1b gene expression between NOT and 
CWI (P = 0.185, ES 0.29 Small) was evident. No signifi-
cant interaction effect was present (P = 0.092).
Experiment 2
Exercise evoked an increase in the expression of Exon 1a 
mRNA, peaking immediately post exercise (~ 1.5–twofold 
change from Pre, ES 1.07 Moderate) before decreasing 
towards pre-exercise values at 3 h post-exercise (~ 1–1.5-
fold change from Pre, P = 0.065, ES 0.33 Small, Fig. 3). 
No statistical significance was present between condi-
tions or for the change over time (P = 0.086 and 0.492, 
respectively). Exercise evoked an increase in the expres-
sion of Exon1b mRNA, with the greatest increases seen at 
3 h post-exercise (CON LOW and CWI LOW ~ 159-fold 
change from Pre, CON VLOW ~ 58-fold change from Pre, 
CWI VLOW ~ 56-fold change from Pre, P = 0.057, ES 1.20 
Moderate/Large). Significant differences were observed 
between conditions (P = 0.035, Fig. 3) with both LOW 
limbs having greater expression than their corresponding 
VLOW limb at 3 h post-exercise (CON P = 0.025, ES 0.67 
Moderate; CWI P = 0.062, ES 1.14 Large). No difference 
was present in both VLOW and LOW limbs when the 
CWI intervention was applied (VLOW P = 0.398, ES 0.26 
Small; LOW P = 0.966, ES 0.007 Trivial) suggesting that a 
cold-induced response in Exon 1b gene expression was not 
present. No significant interaction was seen (P = 0.111).
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Discussion
This is the first study to investigate the relative influence of 
post-exercise cooling as well as the impact of reduced gly-
cogen availability alone, and in combination, on promoter-
specific mRNA expression of the transcriptional co-activator 
PGC-1α. Experiment 1 provided novel results demonstrating 
PGC-1α mRNA expression from the alternative promoter 
(Exon 1b) mirrors the pattern of expression for total PGC-1α 
mRNA previously described (Allan et al. 2017) (Fig. 2). 
Thus, the contribution to total PGC-1α mRNA expression 
post-exercise is likely a result of changes occurring from 
the alternative promoter (Exon 1b). Moreover, a systemic 
response to CWI was seen in the alternative promoter (Exon 
1b) with large (~ 2000) fold changes from pre-exercise in 
the immersed and contralateral non-immersed limbs, ver-
sus a non-immersed control (< 1000-fold change from 
Pre) suggesting the response occurs independent of tissue 
temperature.
When muscle glycogen availability is very low (Experi-
ment 2) (< 150 mmol·kg−1dw; VLOW), the cold-induced 
augmented gene expression for total PGC-1α mRNA was 
abolished (Allan et al. 2019). New analysis of RNA sam-
ples herein focussing on the exon-specific response high-
lights VLOW glycogen limbs showing reduced mRNA 
expression via the alternative promoter (Exon 1b) versus 
the contralateral LOW glycogen limb, supporting the recent 
data indicating a glycogen threshold for adequate increases 
in gene expression to occur (Impey et al. 2018; Hearris 
et al. 2019). Moreover, a cold stimulus had no influence 
upon promoter-specific expression (Exon 1a and 1b) when 
glycogen concentration was low. Indeed, the combination 
of very low glycogen availability and post-exercise CWI 
showed the largest impaired response in gene expression 
of PGC-1α, irrespective of promoter region (Exon 1a and 
1b). In Experiment 1, expression from the canonical pro-
moter (Exon1a) showed a significant increase post-exercise 
in all limbs (two–fourfold change from Pre, P < 0.05). Larger 
fold changes were present in expression from the alternative 
promoter (Exon1b), with values ranging ~ 1000–2000-fold 
increases from pre-exercise values (P < 0.05). The sizeable 
difference in change of expression between the different pro-
moter regions was likely due to the differential expression 
at pre-exercise (rest) and response to an exercise stimulus. 
Indeed, Exon 1a is constitutively expressed at higher levels 
basally (at rest) to a greater extent than Exon 1b, whilst Exon 
Fig. 2  PGC-1α mRNA and specific to Exon 1a (a) and Exon 1b 
(b) ΔΔCT fold change in expression value with the calibrator as pre-
exercise and the reference gene as GAPDH. Values are mean ± SEM. 
*Significantly different from pre-exercise (P < 0.05). #Significantly 
different from CON (P < 0.05). $ (P = 0.07) vs CON. + 3 h = 3 h post-
exercise. Total PGC-1α mRNA (c) redrawn from Allan et al. (J Appl 
Physiol. 2017; 123 (2): 451–459) as mean ± SEM
▸
2492 European Journal of Applied Physiology (2020) 120:2487–2493
1 3
1b is more responsive to an exercise stimulus (Martinez-
Redondo et al. 2015; Popov et al. 2015b). In the present 
study, the pattern of response following exercise from the 
alternative (Exon 1b) promoter closely mirrored that of 
total PGC-1α gene expression seen in the same subjects 
previously (Allan et al. 2017), offering support to evidence 
showing the response of total PGC-1α mRNA to acute exer-
cise is largely driven by the alternative promoter (Exon 1b) 
(Norrbom et al. 2011; Ydfors et al. 2013; Silvennoinen et al. 
2015; Popov et al. 2015b). Additionally, new data herein 
to investigate the impact of commencing exercise with low 
glycogen availability combined with post-exercise cooling 
on the promoter-specific response (Experiment 2) show that 
PGC-1α alternative promoter (Exon 1b) expression con-
tinued to rise at 3 h post-exercise in all conditions, whilst 
expression from the canonical promoter (Exon 1a) decreased 
between the same time points (post-exercise–3 h post-exer-
cise). This emphasises the role of the alternative promoter 
to the exercise-induced augmentation in total PGC-1α gene 
expression (Allan et al. 2017, 2019). Importantly, in Experi-
ment 1, PGC-1α gene expression from the alternative pro-
moter (Exon 1b) showed large increases in response to high-
intensity intermittent cycling (CON, < 1000-fold change 
from Pre), which was augmented even further in limbs 
exposed to systemic cold stress (NOT and CWI, ~ 2000-fold 
change from Pre, P = 0.07 and < 0.05 vs. CON, respectively). 
Indeed, the same pattern of response was observed in total 
PGC-1α mRNA (Allan et al. 2017), and the present data 
suggest that the contribution to cold-induced total PGC-1α 
gene expression is also driven by the alternative (Exon1b), 
and not the canonical (Exon1a) promoter region. These data 
are the first to show such a promoter-specific response to 
cold in animal or human studies.
In conclusion, this is the first study to show the systemic 
cold-induced augmentation of total PGC-1α as seen pre-
viously (Allan et al. 2017) is largely a result of increased 
expression from the alternative promoter (Exon 1b), rather 
than canonical promoter (Exon 1a). Evidence herein fur-
ther supports the notion that PGC-1α gene expression from 
the alternative promoter (Exon 1b) is more reactive to an 
exercise stimulus than the canonical promoter region; with 
Exon 1b demonstrating lower levels at baseline, but more 
responsive to cold and exercise so demonstrating large fold 
increases. Whereas, Exon 1a was expressed more highly at 
rest and was less responsive to exercise and the cold and so 
demonstrates smaller fold increases. Moreover, commencing 
exercise with extremely low glycogen concentrations seems 
to negate the expected increase in PGC-1α gene expression 
irrespective of promoter region (Exon 1a and b), supporting 
the recent glycogen threshold hypothesis (Impey et al. 2018; 
Hearris et al. 2019). These data also provides greater sup-
port to the knowledge that post-exercise cooling may benefit 
important molecular signals of mitochondrial biogenesis, 
Fig. 3  PGC-1α mRNA specific to Exon 1a (a) and Exon 1b (b) ΔΔCT 
fold change in expression with the calibrator as pre-exercise and the 
reference gene as GAPDH. Values are mean ± SEM. $ Trend towards 
increase from pre-exercise (a P = 0.065, b P = 0.057). *Significantly 
different from corresponding LOW limb (P = 0.025). + Different from 
corresponding LOW limb (P = 0.062). + 3 h = 3 h post-exercise. Total 
PGC-1α mRNA (c) redrawn from Allan et  al. (Physiol Rep. 2019; 
7(11): e14082) as mean ± SEM. iSignificantly less than CON LOW 
(P < 0.05), ii greater than CON VLOW (P = 0.05), iii Significantly 
less than CWI LOW (P = 0.019), ivSignificantly greater than pre- and 
post-exercise (P < 0.001)
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allowing confidence in the fact that endurance adapta-
tion may be augmented following such modalities. Future 
research should look to include assessment of PGC-1α pro-
moter-specific gene expression to allow greater mechanistic 
understanding of this important transcriptional co-activator.
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